The Abbott Pandemic Defense Coalition: a unique multisector approach adds to global pandemic preparedness efforts

•Enhanced capacity for the detection of pandemic threats is needed globally.•Abbott launched the Abbott Pandemic Defense Coalition (APDC) in early 2021.•The APDC aims for the early detection of infectious disease threats of pandemic potential.•APDC has the novel capacity to rapidly develop and deplo...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of infectious diseases Vol. 117; pp. 356 - 360
Main Authors Averhoff, Francisco, Berg, Michael, Rodgers, Mary, Osmanov, Saladin, Luo, Xinxin, Anderson, Mark, Meyer, Todd, Landay, Alan, Gamkrelidze, Amiran, Kallas, Esper G., Ciuoderis, Karl, Hernandez, Juan Pablo, Henry, Jean Hugues, Osorio, Jorge, Lindo, John, Deshommes, Johnson, Anzinger, Joshua, Manasa, Justen, Alkashvili, Maia, Souleyman, Mboup, Kaleebu, Pontiano, Correa-Oliveira, Rodrigo, Solomon, Sunil, de Olivera, Tulio, Suputtamongkol, Yupin, Cloherty, Gavin
Format Journal Article
LanguageEnglish
Published Canada Elsevier Ltd 01.04.2022
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract •Enhanced capacity for the detection of pandemic threats is needed globally.•Abbott launched the Abbott Pandemic Defense Coalition (APDC) in early 2021.•The APDC aims for the early detection of infectious disease threats of pandemic potential.•APDC has the novel capacity to rapidly develop and deploy diagnostics targeting new pathogens. Detection and epidemiologic characterization of infectious disease outbreaks are key for early identification and response to potential pandemic threats. The rapid global spread of severe SARS-CoV-2 in 2020 highlighted the critical role of diagnostics in understanding the epidemiology of the virus early in the pandemic. As a natural extension of Abbott's work in diagnostics, virus discovery, and virus surveillance, the Abbott Pandemic Defense Coalition (APDC) was launched in early 2021. The APDC is a global multisector scientific and public health partnership whose primary objective is the early detection and mitigation of infectious disease threats of pandemic potential. As of January 2022, the APDC network has partners on 5 continents including academic institutions, governmental, and nongovernmental organizations. A novel element of the APDC is the capacity for early development and rapid deployment of scalable, quality diagnostics targeting newly identified pathogens of pandemic potential.
AbstractList Detection and epidemiologic characterization of infectious disease outbreaks are key for early identification and response to potential pandemic threats. The rapid global spread of severe SARS-CoV-2 in 2020 highlighted the critical role of diagnostics in understanding the epidemiology of the virus early in the pandemic. As a natural extension of Abbott's work in diagnostics, virus discovery, and virus surveillance, the Abbott Pandemic Defense Coalition (APDC) was launched in early 2021. The APDC is a global multisector scientific and public health partnership whose primary objective is the early detection and mitigation of infectious disease threats of pandemic potential. As of January 2022, the APDC network has partners on 5 continents including academic institutions, governmental, and nongovernmental organizations. A novel element of the APDC is the capacity for early development and rapid deployment of scalable, quality diagnostics targeting newly identified pathogens of pandemic potential.Detection and epidemiologic characterization of infectious disease outbreaks are key for early identification and response to potential pandemic threats. The rapid global spread of severe SARS-CoV-2 in 2020 highlighted the critical role of diagnostics in understanding the epidemiology of the virus early in the pandemic. As a natural extension of Abbott's work in diagnostics, virus discovery, and virus surveillance, the Abbott Pandemic Defense Coalition (APDC) was launched in early 2021. The APDC is a global multisector scientific and public health partnership whose primary objective is the early detection and mitigation of infectious disease threats of pandemic potential. As of January 2022, the APDC network has partners on 5 continents including academic institutions, governmental, and nongovernmental organizations. A novel element of the APDC is the capacity for early development and rapid deployment of scalable, quality diagnostics targeting newly identified pathogens of pandemic potential.
•Enhanced capacity for the detection of pandemic threats is needed globally.•Abbott launched the Abbott Pandemic Defense Coalition (APDC) in early 2021.•The APDC aims for the early detection of infectious disease threats of pandemic potential.•APDC has the novel capacity to rapidly develop and deploy diagnostics targeting new pathogens. Detection and epidemiologic characterization of infectious disease outbreaks are key for early identification and response to potential pandemic threats. The rapid global spread of severe SARS-CoV-2 in 2020 highlighted the critical role of diagnostics in understanding the epidemiology of the virus early in the pandemic. As a natural extension of Abbott's work in diagnostics, virus discovery, and virus surveillance, the Abbott Pandemic Defense Coalition (APDC) was launched in early 2021. The APDC is a global multisector scientific and public health partnership whose primary objective is the early detection and mitigation of infectious disease threats of pandemic potential. As of January 2022, the APDC network has partners on 5 continents including academic institutions, governmental, and nongovernmental organizations. A novel element of the APDC is the capacity for early development and rapid deployment of scalable, quality diagnostics targeting newly identified pathogens of pandemic potential.
Detection and epidemiologic characterization of infectious disease outbreaks are key for early identification and response to potential pandemic threats. The rapid global spread of severe SARS-CoV-2 in 2020 highlighted the critical role of diagnostics in understanding the epidemiology of the virus early in the pandemic. As a natural extension of Abbott's work in diagnostics, virus discovery, and virus surveillance, the Abbott Pandemic Defense Coalition (APDC) was launched in early 2021. The APDC is a global multisector scientific and public health partnership whose primary objective is the early detection and mitigation of infectious disease threats of pandemic potential. As of January 2022, the APDC network has partners on 5 continents including academic institutions, governmental, and nongovernmental organizations. A novel element of the APDC is the capacity for early development and rapid deployment of scalable, quality diagnostics targeting newly identified pathogens of pandemic potential.
Author Berg, Michael
Osmanov, Saladin
Correa-Oliveira, Rodrigo
Cloherty, Gavin
Gamkrelidze, Amiran
Meyer, Todd
Suputtamongkol, Yupin
Luo, Xinxin
Alkashvili, Maia
Hernandez, Juan Pablo
Kaleebu, Pontiano
Souleyman, Mboup
Kallas, Esper G.
Rodgers, Mary
Landay, Alan
Ciuoderis, Karl
Deshommes, Johnson
Osorio, Jorge
Lindo, John
de Olivera, Tulio
Averhoff, Francisco
Henry, Jean Hugues
Manasa, Justen
Anderson, Mark
Solomon, Sunil
Anzinger, Joshua
Author_xml – sequence: 1
  givenname: Francisco
  surname: Averhoff
  fullname: Averhoff, Francisco
  email: francisco.averhoff@abbott.com
  organization: Abbott Diagnostics, Abbott Park, IL, USA
– sequence: 2
  givenname: Michael
  orcidid: 0000-0003-0233-5819
  surname: Berg
  fullname: Berg, Michael
  email: michael.berg@abbott.com
  organization: Abbott Diagnostics, Abbott Park, IL, USA
– sequence: 3
  givenname: Mary
  surname: Rodgers
  fullname: Rodgers, Mary
  organization: Abbott Diagnostics, Abbott Park, IL, USA
– sequence: 4
  givenname: Saladin
  surname: Osmanov
  fullname: Osmanov, Saladin
  organization: Abbott Diagnostics (deceased), Abbott Park, IL, USA
– sequence: 5
  givenname: Xinxin
  surname: Luo
  fullname: Luo, Xinxin
  organization: Abbott Diagnostics, Abbott Park, IL, USA
– sequence: 6
  givenname: Mark
  surname: Anderson
  fullname: Anderson, Mark
  organization: Abbott Diagnostics, Abbott Park, IL, USA
– sequence: 7
  givenname: Todd
  surname: Meyer
  fullname: Meyer, Todd
  organization: Abbott Diagnostics, Abbott Park, IL, USA
– sequence: 8
  givenname: Alan
  surname: Landay
  fullname: Landay, Alan
  organization: Rush University Medical Center, Chicago, IL, USA
– sequence: 9
  givenname: Amiran
  surname: Gamkrelidze
  fullname: Gamkrelidze, Amiran
  organization: National Center for Disease Control, Tbilisi, Georgia
– sequence: 10
  givenname: Esper G.
  surname: Kallas
  fullname: Kallas, Esper G.
  organization: University of Sao Paulo, Sao Paulo, Brazil
– sequence: 11
  givenname: Karl
  surname: Ciuoderis
  fullname: Ciuoderis, Karl
  organization: Colombia Wisconsin One Health, University of Wisconsin & National University of Colombia, Medellin, Colombia
– sequence: 12
  givenname: Juan Pablo
  orcidid: 0000-0003-0404-9947
  surname: Hernandez
  fullname: Hernandez, Juan Pablo
  organization: Colombia Wisconsin One Health, University of Wisconsin & National University of Colombia, Medellin, Colombia
– sequence: 13
  givenname: Jean Hugues
  surname: Henry
  fullname: Henry, Jean Hugues
  organization: Quisqueya University, Port-au-Prince, Haiti
– sequence: 14
  givenname: Jorge
  surname: Osorio
  fullname: Osorio, Jorge
  organization: Colombia Wisconsin One Health, University of Wisconsin & National University of Colombia, Medellin, Colombia
– sequence: 15
  givenname: John
  surname: Lindo
  fullname: Lindo, John
  organization: University of the West Indies, Kingston, Jamaica
– sequence: 16
  givenname: Johnson
  surname: Deshommes
  fullname: Deshommes, Johnson
  organization: Quisqueya University, Port-au-Prince, Haiti
– sequence: 17
  givenname: Joshua
  orcidid: 0000-0002-4541-4683
  surname: Anzinger
  fullname: Anzinger, Joshua
  organization: University of the West Indies, Kingston, Jamaica
– sequence: 18
  givenname: Justen
  surname: Manasa
  fullname: Manasa, Justen
  organization: University of Zimbabwe, Harare, Zimbabwe
– sequence: 19
  givenname: Maia
  surname: Alkashvili
  fullname: Alkashvili, Maia
  organization: National Center for Disease Control, Tbilisi, Georgia
– sequence: 20
  givenname: Mboup
  surname: Souleyman
  fullname: Souleyman, Mboup
  organization: Institute for Health Research, Epidemiologic Surveillance and Training (IRESSEF), Dakar, Senegal
– sequence: 21
  givenname: Pontiano
  surname: Kaleebu
  fullname: Kaleebu, Pontiano
  organization: Uganda Virus Research Institute, Entebbe, Uganda
– sequence: 22
  givenname: Rodrigo
  surname: Correa-Oliveira
  fullname: Correa-Oliveira, Rodrigo
  organization: Foundation Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil
– sequence: 23
  givenname: Sunil
  surname: Solomon
  fullname: Solomon, Sunil
  organization: Johns Hopkins University School of Medicine, USA & YRG CARE, Chennai, India
– sequence: 24
  givenname: Tulio
  surname: de Olivera
  fullname: de Olivera, Tulio
  organization: Centre for Epidemic Response and Innovation, Stellenbosch University, Stellenbosch, South Africa
– sequence: 25
  givenname: Yupin
  surname: Suputtamongkol
  fullname: Suputtamongkol, Yupin
  organization: Mahidol University, Bangkok, Thailand
– sequence: 26
  givenname: Gavin
  surname: Cloherty
  fullname: Cloherty, Gavin
  organization: Abbott Diagnostics
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35134559$$D View this record in MEDLINE/PubMed
BookMark eNqFUl1rHSEQXUpK89H-gT4UH_tyb9VdVw2lENKvQKB9SJ9l1p1NvPXqRr2B_Pt6e5PQ5CGFAcWZc2accw6bvRADNs1bRpeMsv7DaulWblxyyvmS1qDsRXPAlFSLVjC2V--csoWWjO83hzmvKKVd36tXzX7Nt50Q-qC5vrhCcjIMsRTyE8KIa2fJZ5wwZCSnEbwrLoZjAmQT3PUGyXrji8toS0wE5jlFsFcExjGTEsmljwN4Mt8TzQlnSDgGzJngNMVU8uvm5QQ-45u786j59fXLxen3xfmPb2enJ-cLKyQvC2EBLdXDJMapHykIGLQdLG21VF2vOYCeoP6Co5B9JxRqzhiqiWI_DrZr26PmbMc7RliZObk1pFsTwZm_DzFdGkjFWY9G9VJqYTnrJ9q1ArS2bctbVFIOyk62cn3acc2bYY2jxVAS-EekjzPBXZnLeGOUYrITshK8vyNIsW4xF7N22aL3EDBusuE9l6xte72d-92_vR6a3GtWC_iuwKaYc8LpoYRRszWGWZmtMczWGIbWoKyC1BOQdQW22tZ5nX8e-nEHxarWjcNksnUYLI4uVR_Udbrn4cdP4Na74Cz433j7P_Af4tno-w
CitedBy_id crossref_primary_10_3389_fmicb_2024_1362714
crossref_primary_10_3389_fmicb_2024_1419637
crossref_primary_10_3201_eid3010_240170
crossref_primary_10_3389_fpubh_2024_1323481
crossref_primary_10_1093_infdis_jiad406
crossref_primary_10_3201_eid2808_221006
crossref_primary_10_15446_dyna_v90n230_111828
crossref_primary_10_3389_feduc_2023_1241031
crossref_primary_10_1016_j_meegid_2024_105667
crossref_primary_10_3390_v15041022
Cites_doi 10.1038/s41598-018-30078-5
10.1016/j.jviromet.2016.12.013
10.1016/j.ebiom.2021.103258
10.1016/j.virol.2017.01.008
10.1111/1468-0009.12186
10.7326/M17-0085
10.1128/JCM.00515-16
10.1016/j.ijid.2021.08.021
10.1097/QAI.0000000000002246
10.1371/journal.ppat.1005325
ContentType Journal Article
Copyright 2022 The Author(s)
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.
2022 The Author(s) 2022
Copyright_xml – notice: 2022 The Author(s)
– notice: Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.
– notice: 2022 The Author(s) 2022
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1016/j.ijid.2022.02.001
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic



MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 1878-3511
EndPage 360
ExternalDocumentID oai_doaj_org_article_867795c216f0435a99c3323e877b8cfc
PMC8817457
35134559
10_1016_j_ijid_2022_02_001
S1201971222000807
Genre Journal Article
GroupedDBID ---
--K
.1-
.FO
.~1
0R~
1B1
1P~
1~.
1~5
29J
3O-
4.4
457
4G.
53G
5GY
5VS
7-5
71M
7X7
88E
8C1
8FI
8FJ
8FQ
8R4
8R5
AAEDW
AAFWJ
AAIKJ
AALRI
AAQFI
AAQXK
AARKO
AAXUO
AAYWO
ABBQC
ABFRF
ABMAC
ABUWG
ABWVN
ACGFO
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADVLN
AEFWE
AEKER
AENEX
AEUPX
AEVXI
AEXQZ
AFJKZ
AFKRA
AFPKN
AFPUW
AFRHN
AFTJW
AGEKW
AGHFR
AGQPQ
AGYEJ
AHMBA
AIGII
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
ASPBG
AVWKF
AZFZN
BAWUL
BCNDV
BENPR
BPHCQ
BR6
BVXVI
CCPQU
CS3
DIK
DU5
DWQXO
E3Z
EBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FNPLU
FYUFA
G-Q
GBLVA
GROUPED_DOAJ
GX1
HMCUK
HVGLF
HZ~
IHE
IXB
J1W
KQ8
M1P
M3C
M3G
M41
MO0
N9A
O-L
O9-
OD-
OK1
OO.
OZT
P-8
P-9
P2P
PC.
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
Q2X
Q38
QTD
R2-
ROL
RPZ
RWL
RXW
SDF
SDG
SEL
SES
SEW
SSZ
TAE
UKHRP
UNMZH
Z5R
0SF
3V.
6I.
AACTN
AAFTH
ABVKL
AFCTW
NCXOZ
RIG
AAYXX
ALIPV
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c572t-5caec09bf5df6d0a5ab9cbc039784692aa9fa1342e576458e9211e8f0e6dbc433
IEDL.DBID DOA
ISSN 1201-9712
1878-3511
IngestDate Wed Aug 27 01:32:54 EDT 2025
Thu Aug 21 18:16:12 EDT 2025
Thu Jul 10 22:27:29 EDT 2025
Tue Apr 29 09:42:36 EDT 2025
Thu Apr 24 23:11:32 EDT 2025
Tue Jul 01 04:30:10 EDT 2025
Fri Feb 23 02:38:45 EST 2024
Tue Aug 26 16:32:04 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords emerging pathogens, virus discovery, surveillance, public health
Pandemic preparedness
Language English
License This is an open access article under the CC BY-NC-ND license.
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c572t-5caec09bf5df6d0a5ab9cbc039784692aa9fa1342e576458e9211e8f0e6dbc433
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
For the Abbott Pandemic Defense Coalition
ORCID 0000-0003-0404-9947
0000-0002-4541-4683
0000-0003-0233-5819
OpenAccessLink https://doaj.org/article/867795c216f0435a99c3323e877b8cfc
PMID 35134559
PQID 2627133693
PQPubID 23479
PageCount 5
ParticipantIDs doaj_primary_oai_doaj_org_article_867795c216f0435a99c3323e877b8cfc
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8817457
proquest_miscellaneous_2627133693
pubmed_primary_35134559
crossref_primary_10_1016_j_ijid_2022_02_001
crossref_citationtrail_10_1016_j_ijid_2022_02_001
elsevier_sciencedirect_doi_10_1016_j_ijid_2022_02_001
elsevier_clinicalkey_doi_10_1016_j_ijid_2022_02_001
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-04-01
PublicationDateYYYYMMDD 2022-04-01
PublicationDate_xml – month: 04
  year: 2022
  text: 2022-04-01
  day: 01
PublicationDecade 2020
PublicationPlace Canada
PublicationPlace_xml – name: Canada
PublicationTitle International journal of infectious diseases
PublicationTitleAlternate Int J Infect Dis
PublicationYear 2022
Publisher Elsevier Ltd
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases
– name: Elsevier
References Martin, Fall (bib0013) 2021
Rodgers, Vallari, Harris, Yamaguchi, Holzmayer, Forberg, Berg, Kenmenge, Ngansop, Awazi, Mbanya, Kaptue, Brennan, Cloherty, Ndembi (bib0016) 2017; 504
Coller, Berg, Frankel, Forberg, Surani, Chiu, Hackett, Dawson (bib0009) 2016; 54
US Government Accountability Office, GAO. 2021. ‘Operation Warp Speed: Accelerated COVID-19 Vaccine Development Status and Efforts to Address Manufacturing Challenges’
Abbott Diagnostics, ADD. 2021a.
Abbott Diagnostics, ADD. 2021b.
Morens, Daszak, Markel, Taubenberger (bib0015) 2020
Rodgers, Olivo, Vallari, Harris, Lark, Luo, Berg, Meyer, Mohaimani, Orf, Goldstein, Fox, Hirschhorn, Glen, Nolte, Landay, Jennings, Moy, Servellita, Chiu, Batra, Snell, Nebbia, Douthwaite, Tanuri, Singh, Oliveira, Ahouidi, Mboup, Daghfal, Roth, Huang, Kovacs, Cloherty (bib0014) 2021
.
Frankel, Forberg, Coller, Berg, Hackett, Cloherty, Dawson (bib0010) 2017; 241
Berg, Olivo, Harris, Rodgers, James, Mampunza, Niles, Baer, Yamaguchi, Kaptue, Laeyendecker, Quinn, McArthur, Cloherty (bib0007) 2021; 65
Berg, Lee, Coller, Frankel, Aronsohn, Cheng, Forberg, Marcinkus, Naccache, Dawson, Brennan, Jensen, Hackett, Chiu (bib0006) 2015; 11
Gostin, Katz (bib0011) 2016; 94
United Kingdom G7, UKG7. 2021. ‘100 Days Mission to respond to future pandemics: a report to the G7’
Abbott Laboratories, Abbott. 2020.
Yamaguchi, Vallari, McArthur, Sthreshley, Cloherty, Berg, Rodgers (bib0019) 2020; 83
Abbott Laboratories, Abbott. 2021.
Abid, Uddin, Muhammad, Awan, Applegate, Dore, Cloherty, Hamid (bib0005) 2021
Butler, Rodgers, Coller, Barnaby, Krilich, Olivo, Cassidy, Mbanya, Kaptue, Ndembi, Cloherty (bib0008) 2018; 8
Kandathil, Breitwieser, Sachithanandham, Robinson, Mehta, Timp, Salzberg, Thomas, Balagopal (bib0012) 2017; 167
Butler (10.1016/j.ijid.2022.02.001_bib0008) 2018; 8
Martin (10.1016/j.ijid.2022.02.001_bib0013) 2021
Berg (10.1016/j.ijid.2022.02.001_bib0006) 2015; 11
Kandathil (10.1016/j.ijid.2022.02.001_bib0012) 2017; 167
Rodgers (10.1016/j.ijid.2022.02.001_bib0014) 2021
Coller (10.1016/j.ijid.2022.02.001_bib0009) 2016; 54
Berg (10.1016/j.ijid.2022.02.001_bib0007) 2021; 65
10.1016/j.ijid.2022.02.001_bib0001
Gostin (10.1016/j.ijid.2022.02.001_bib0011) 2016; 94
10.1016/j.ijid.2022.02.001_bib0002
10.1016/j.ijid.2022.02.001_bib0003
10.1016/j.ijid.2022.02.001_bib0004
Frankel (10.1016/j.ijid.2022.02.001_bib0010) 2017; 241
Yamaguchi (10.1016/j.ijid.2022.02.001_bib0019) 2020; 83
Morens (10.1016/j.ijid.2022.02.001_bib0015) 2020
10.1016/j.ijid.2022.02.001_bib0017
Rodgers (10.1016/j.ijid.2022.02.001_bib0016) 2017; 504
10.1016/j.ijid.2022.02.001_bib0018
Abid (10.1016/j.ijid.2022.02.001_bib0005) 2021
References_xml – reference: Abbott Diagnostics, ADD. 2021a. ‘
– volume: 54
  start-page: 2023
  year: 2016
  end-page: 2030
  ident: bib0009
  article-title: Antibodies to the Novel Human Pegivirus 2 Are Associated with Active and Resolved Infections
  publication-title: J Clin Microbiol
– volume: 8
  start-page: 11617
  year: 2018
  ident: bib0008
  article-title: High prevalence of hepatitis delta virus in Cameroon
  publication-title: Sci Rep
– reference: Abbott Diagnostics, ADD. 2021b. ‘
– reference: .
– start-page: 11
  year: 2021
  ident: bib0005
  article-title: Evaluation of Hepatitis C Virus Core Antigen Assay in a Resource-Limited Setting in Pakistan
  publication-title: Diagnostics (Basel)
– reference: ’.
– reference: US Government Accountability Office, GAO. 2021. ‘Operation Warp Speed: Accelerated COVID-19 Vaccine Development Status and Efforts to Address Manufacturing Challenges’,
– reference: United Kingdom G7, UKG7. 2021. ‘100 Days Mission to respond to future pandemics: a report to the G7’,
– volume: 65
  year: 2021
  ident: bib0007
  article-title: A high prevalence of potential HIV elite controllers identified over 30 years in Democratic Republic of Congo
  publication-title: EBioMedicine
– reference: Abbott Laboratories, Abbott. 2020. ‘
– volume: 83
  start-page: 319
  year: 2020
  end-page: 322
  ident: bib0019
  article-title: Brief Report: Complete Genome Sequence of CG-0018a-01 Establishes HIV-1 Subtype L’
  publication-title: J Acquir Immune Defic Syndr
– volume: 241
  start-page: 34
  year: 2017
  end-page: 40
  ident: bib0010
  article-title: Development of a high-throughput multiplexed real time RT-PCR assay for detection of human pegivirus 1 and 2
  publication-title: J Virol Methods
– year: 2021
  ident: bib0013
  article-title: Field Epidemiology Training Programs to accelerate public health workforce development and global health security
  publication-title: Int J Infect Dis
– volume: 504
  start-page: 141
  year: 2017
  end-page: 151
  ident: bib0016
  article-title: Identification of rare HIV-1 Group N, HBV AE, and HTLV-3 strains in rural South Cameroon
  publication-title: Virology
– volume: 94
  start-page: 264
  year: 2016
  end-page: 313
  ident: bib0011
  article-title: The International Health Regulations: The Governing Framework for Global Health Security
  publication-title: Milbank Q
– reference: Abbott Laboratories, Abbott. 2021. ‘
– volume: 11
  year: 2015
  ident: bib0006
  article-title: Discovery of a Novel Human Pegivirus in Blood Associated with Hepatitis C Virus Co-Infection’
  publication-title: PLoS Pathog
– year: 2021
  ident: bib0014
  article-title: Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests
  publication-title: Journal of Clinical Virology (in review)
– volume: 167
  start-page: 1
  year: 2017
  end-page: 7
  ident: bib0012
  article-title: Presence of Human Hepegivirus-1 in a Cohort of People Who Inject Drugs
  publication-title: Ann Intern Med
– start-page: 11
  year: 2020
  ident: bib0015
  article-title: Pandemic COVID-19 Joins History’s Pandemic Legion
  publication-title: mBio
– volume: 8
  start-page: 11617
  year: 2018
  ident: 10.1016/j.ijid.2022.02.001_bib0008
  article-title: High prevalence of hepatitis delta virus in Cameroon
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-30078-5
– volume: 241
  start-page: 34
  year: 2017
  ident: 10.1016/j.ijid.2022.02.001_bib0010
  article-title: Development of a high-throughput multiplexed real time RT-PCR assay for detection of human pegivirus 1 and 2
  publication-title: J Virol Methods
  doi: 10.1016/j.jviromet.2016.12.013
– volume: 65
  year: 2021
  ident: 10.1016/j.ijid.2022.02.001_bib0007
  article-title: A high prevalence of potential HIV elite controllers identified over 30 years in Democratic Republic of Congo
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2021.103258
– ident: 10.1016/j.ijid.2022.02.001_bib0003
– start-page: 11
  year: 2021
  ident: 10.1016/j.ijid.2022.02.001_bib0005
  article-title: Evaluation of Hepatitis C Virus Core Antigen Assay in a Resource-Limited Setting in Pakistan
  publication-title: Diagnostics (Basel)
– ident: 10.1016/j.ijid.2022.02.001_bib0004
– start-page: 11
  year: 2020
  ident: 10.1016/j.ijid.2022.02.001_bib0015
  article-title: Pandemic COVID-19 Joins History’s Pandemic Legion
  publication-title: mBio
– volume: 504
  start-page: 141
  year: 2017
  ident: 10.1016/j.ijid.2022.02.001_bib0016
  article-title: Identification of rare HIV-1 Group N, HBV AE, and HTLV-3 strains in rural South Cameroon
  publication-title: Virology
  doi: 10.1016/j.virol.2017.01.008
– volume: 94
  start-page: 264
  year: 2016
  ident: 10.1016/j.ijid.2022.02.001_bib0011
  article-title: The International Health Regulations: The Governing Framework for Global Health Security
  publication-title: Milbank Q
  doi: 10.1111/1468-0009.12186
– ident: 10.1016/j.ijid.2022.02.001_bib0002
– volume: 167
  start-page: 1
  year: 2017
  ident: 10.1016/j.ijid.2022.02.001_bib0012
  article-title: Presence of Human Hepegivirus-1 in a Cohort of People Who Inject Drugs
  publication-title: Ann Intern Med
  doi: 10.7326/M17-0085
– ident: 10.1016/j.ijid.2022.02.001_bib0001
– ident: 10.1016/j.ijid.2022.02.001_bib0018
– volume: 54
  start-page: 2023
  year: 2016
  ident: 10.1016/j.ijid.2022.02.001_bib0009
  article-title: Antibodies to the Novel Human Pegivirus 2 Are Associated with Active and Resolved Infections
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.00515-16
– year: 2021
  ident: 10.1016/j.ijid.2022.02.001_bib0013
  article-title: Field Epidemiology Training Programs to accelerate public health workforce development and global health security
  publication-title: Int J Infect Dis
  doi: 10.1016/j.ijid.2021.08.021
– volume: 83
  start-page: 319
  year: 2020
  ident: 10.1016/j.ijid.2022.02.001_bib0019
  article-title: Brief Report: Complete Genome Sequence of CG-0018a-01 Establishes HIV-1 Subtype L’
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0000000000002246
– volume: 11
  year: 2015
  ident: 10.1016/j.ijid.2022.02.001_bib0006
  article-title: Discovery of a Novel Human Pegivirus in Blood Associated with Hepatitis C Virus Co-Infection’
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1005325
– ident: 10.1016/j.ijid.2022.02.001_bib0017
– year: 2021
  ident: 10.1016/j.ijid.2022.02.001_bib0014
  article-title: Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests
  publication-title: Journal of Clinical Virology (in review)
SSID ssj0004668
Score 2.3861873
Snippet •Enhanced capacity for the detection of pandemic threats is needed globally.•Abbott launched the Abbott Pandemic Defense Coalition (APDC) in early 2021.•The...
Detection and epidemiologic characterization of infectious disease outbreaks are key for early identification and response to potential pandemic threats. The...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 356
SubjectTerms COVID-19 - epidemiology
COVID-19 - prevention & control
Disease Outbreaks
emerging pathogens, virus discovery, surveillance, public health
Humans
Pandemic preparedness
Pandemics - prevention & control
Public Health
SARS-CoV-2
SummonAdditionalLinks – databaseName: Elsevier SD Freedom Collection
  dbid: .~1
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9QwFA7LPoggouttvBHBN6nT5tI2vq2jyyKsCLqwbyHJJNpF23Eur_52z0nSYauwgo9tk15yTs8l-c4XQl4y5oSMOD9VukJ4owojl7ZonS0tb0vH4-r52cf69Fx8uJAXB2Qx1sIgrDLb_mTTo7XOZ-Z5NOerrpt_rsB3qaYCBxfjHqwoF6JBLX_9q7pSG5nK4aBxga1z4UzCeHWXHbKFMpZ4O6uJc4oc_hMf9XcM-ieU8opvOrlDbuegkh6n975LDnx_RG6c5WXzI3IrTc7RVHN0j_wE5aDHcRcx-glnkX_AxXc-QErr6WLA0BzE9YYauov8rjTCDjdxgp-OLOQUbNaGbgeaOEXoarzRau0jrB2NKPUh4JrEfXJ-8v7L4rTIey8UTjZsW0hnvCuVDXIZ6mVppLHKWVdC-AIRi2LGqGAqLpiHhEXI1ivIJH0bSl8vrROcPyCH_dD7R4Q6CAOMDwYyPSdaBykxZN2CO9uwOnDDZ6QaB127TEyO-2N81yMC7VKjoDQKSpcMYXgz8mrfZ5VoOa5t_RZluW-JlNrxxLD-qrNOaST2U9Kxqg4lxJBGKcc5475tGtu64GaEj5qgx6pVsLNwo-7aR8t9r4le_7Pfi1HZNPzwuIpjej_sNprVDCcWagUD9zAp3_7DuASRQI44I81ELSdfPr3Sd98iqXjbQm4qm8f_-b5PyE08Spimp-Rwu975ZxCube3z-D_-BojKPZk
  priority: 102
  providerName: Elsevier
Title The Abbott Pandemic Defense Coalition: a unique multisector approach adds to global pandemic preparedness efforts
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1201971222000807
https://dx.doi.org/10.1016/j.ijid.2022.02.001
https://www.ncbi.nlm.nih.gov/pubmed/35134559
https://www.proquest.com/docview/2627133693
https://pubmed.ncbi.nlm.nih.gov/PMC8817457
https://doaj.org/article/867795c216f0435a99c3323e877b8cfc
Volume 117
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELWgB4SEEJSvhVIZiRsKOHac2L31g6qAikCi0t4se9ZWt4Ls0t298tsZ20nUUKm9cMlhE2dlz8Qzz37zTMhbzqGSieenGRSVt7qwcuYKBY45oRiItHt--rU-Oas-T-X0ylFfkROW5YHzwH2IemtaAi_rwDC0W61BCC68ahqnIECcfTHm9WBqqIjMRXAY3grdlLwrl8nMrvnFPGqEcp7VOstRSErK_aPIdD3z_JdAeSUiHT8iD7tUku7nLjwmd3y7Te6ddpvl2-RBXpKjudLoCfmNLkH309lh9FtcO_6FN498QCDr6eEiJuRopD1q6SaputJENlylZX3aa49TnKlWdL2gWUmELvsXLS99IrPHqZP6EOJOxFNydvzxx-FJ0Z24UIBs-LqQYD0w7YKchXrGrLROgwOGSQvmKZpbq4MtRcU9wpRKKq8RP3oVmK9nDiohnpGtdtH6F4QCBn_rg0V8B5UCBMKItSsBruF1EFZMSNkPuoFOjjyeivHT9LyzCxMNZaKhDOORfDch74Y2yyzGcePTB9GWw5NRSDv9gO5lOvcyt7nXhIjeE0xfq4qzK75ofuNfy6FVl8nkDOXWdm96ZzP4mce9G9v6xWZleM3jckKtceCeZ-cbOiYkmgSR4YQ0I7cc9Xx8p52fJylxpRCRyubl_xiqV-R-7EqmNe2QrfXlxr_GjG3tdsnd93_K3fSJ4vXT9ACvX76rvznsP4A
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwELZKkaASQlCu5TQSbyhsYsdJzFtZqBboVki0Ut8se9aGVCVZ9njltzO2k1UDUpF4jY_YnvEc9sxnQl4xBrkIcX4yhSS3WiZazE1SgUkNr1Lg4fZ8dlxMT_NPZ-Jsh0z6XBgfVtnJ_ijTg7Tuvoy71Rwv6nr8NUPdJcsMFVywe8pr5HqO29c_Y_DmV3YpOTLmw2HtxFfvMmdikFd9Xnu4UMYicGc20E4BxH-gpP42Qv-MpbyknA7vkNudVUkP4sDvkh3b7JMbs-7efJ_ciqdzNCYd3SM_kTvoQXhGjH7xx8g_sPC9dejTWjppvW2O9HpLNd0EgFca4g5X4YSf9jDkFIXWiq5bGkFF6KLvaLG0Ia7dS1FqnfOXEvfJ6eGHk8k06R5fSECUbJ0I0BZSaZyYu2KeaqGNBAMp2i9oskimtXQ64zmz6LHkorISXUlbudQWcwM55w_IbtM29hGhgHaAtk6jqwd5BegTo9udczAlKxzXfESyftEVdMjk_oGMC9WHoJ0rTyjlCaVS5uPwRuT1ts0i4nJcWfudp-W2psfUDh_a5TfVMZXyyH5SAMsKl6IRqaUEzhm3VVmaChyMCO85QfVpqyhosaP6yl-LbasBY_-z3cue2RTueH-NoxvbblaKFcyfLBQSF-5hZL7txLhAkqCTOCLlgC0HMx-WNPX3gCpeVeicivLxf473Bbk5PZkdqaOPx5-fkD1fEgOcnpLd9XJjn6HttjbPw978DWbJQLU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Abbott+Pandemic+Defense+Coalition%3A+a+unique+multisector+approach+adds+to+global+pandemic+preparedness+efforts&rft.jtitle=International+journal+of+infectious+diseases&rft.au=Averhoff%2C+Francisco&rft.au=Berg%2C+Michael&rft.au=Rodgers%2C+Mary&rft.au=Osmanov%2C+Saladin&rft.date=2022-04-01&rft.pub=Elsevier+Ltd&rft.issn=1201-9712&rft.volume=117&rft.spage=356&rft.epage=360&rft_id=info:doi/10.1016%2Fj.ijid.2022.02.001&rft.externalDocID=S1201971222000807
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1201-9712&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1201-9712&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1201-9712&client=summon